Please use this identifier to cite or link to this item:
Title: Risk factors for recurrence after robot-assisted radical hysterectomy for early-stage cervical cancer: a multicenter retrospective study
Author: Ponce i Sebastià, Jordi
Fernandez Gonzalez, Sergi
Gil Moreno, Antonio
Coronado Martín, Pluvio Jesús
Rosa, Jesús de la
Nabais, Henrique
Hernández, Ginés
Taltavull, Anna
Gilabert-Estelles, Juan
Martinez-Román, Sergio
Barahona, Manel
Barahona, Marc
Martínez-Maestre, María Ángeles
Keywords: Cirurgia
Estudi de casos
Case studies
Issue Date: 16-Nov-2020
Publisher: MDPI
Abstract: This retrospective analysis aimed to assess the risk factors for recurrence in patients diagnosed with early-stage cervical cancer (≤IB1 or IIA1, FIGO 2009) undergoing robot-assisted radical hysterectomy in Spain and Portugal between 2009 and 2018. A second primary objective was to audit the oncological outcomes according to quality indicators (QI) proposed by the European Society of Gynecology Oncology (ESGO). The study population included 239 women. After a median follow-up of 51 months, recurrence occurred in 26 patients (10.9%). Independent factors for recurrence were clinical tumor size > 20 mm (hazard ratio (HR) 2.37), adenocarcinoma as histological type (HR 2.51), positive pelvic lymph nodes (HR 4.83), tumor grade 2 (HR 4.99), tumor grade 3 (HR 8.06), and having not performed sentinel lymph node biopsy (SLNB) (HR 4.08). All 5 QI selected were surpassed by our results. In patients with early-stage cervical cancer undergoing robotic radical hysterectomy, clinicians should be aware that tumor grade 2 and 3, tumor size > 20 mm, adenocarcinoma, positive pelvic nodes, and lack of performance of SLNB are risk factors for recurrence. Fulfillment of QI targets of the ESGO might be considered as an objective oncological outcome indicator supporting the minimally invasive approach for early-stage cervical cancer treatment. KEYWORDS: early-stage cervical cancer; oncological outcome; radical hysterectomy; recurrence; robotic surgery.
Note: Reproducció del document publicat a:
It is part of: Cancers, 2020, vol. 12, num. 11, p. 3387
Related resource:
ISSN: 2072-6694
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
704975.pdf626.75 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons